Genomics Market Analysis and Forecast to 2033: By Products & Services (Consumables & Reagents, Services, Instruments, Systems & Software), Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), Application (Diagnostics, Drug Discovery and Development, Agriculture and Animal Research, Others), Study Type (Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Others), End-Use (Research Centers and Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), and Region

Genomics is the study of genes and their function. The market for genomics is expected to grow in the coming years as the technology becomes more affordable and accessible.

Products in the genomics market include sequencing, microarrays, and PCR. Sequencing is the most popular product, accounting for over half of the market share. Microarrays are used for gene expression and SNP analysis, while PCR is used for DNA amplification and sequencing.

The applications of genomics include drug discovery, disease diagnosis, and agricultural biotechnology. The drug discovery market is the largest application, accounting for over half of the market share. Genomics is also used in disease diagnosis, such as cancer, and in agricultural biotechnology, such as crop improvement.

The global Genomics Market was valued at US$ 45.9 billion in 2023 and it is anticipated to grow up to US$ 126.8 billion by 2033, at a CAGR of 10.5% during the forecast period.

Global Genomics Market Scope and Report Structure

Report Attribute Details
Market Size in 2023USD 45.9 Billion
Market Size in 2033USD 126.8 Billion
Growth Rate (2023-33)10.5%
Historic Period2017-2022
Forecast Period2024-2033
Base Year2023
Segments CoveredTechnology, Application, Product & Services, Study Type, End-Use, and Region
Key CompaniesOxford Nanopore Technologies (U.K), Danaher Corporation (U.S), Thermo Fisher Scientific Inc. (U.S), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S), Bio-Rad Laboratories (U.S), Agilent Technologies (U.S), Eppendorf (Germany), GE Healthcare Inc. (U.S), among others.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Key Trends and Drivers

The key trends in the genomics market are the increasing demand for personalized medicine and the increasing funding for genomics research.

Restraints & Challenges

The key restraints in the market are the high cost of sequencing and the lack of skilled labor. The challenges in the market are the need for data storage and data management, the need for data interpretation and data analysis, and the need for data security.

Global Genomics Market Segmental Overview

The report analyses the global Genomics Market based on technology, application, product & services, study type, end-use, and region.

Global Genomics Market by End User

Based on end user, the Genomics Market is segmented into hospitals & clinics, academic & research institutes, pharmaceutical & biotechnology companies, and others. The academic & research institutes segment is expected to dominate the market during the forecast period.

Global Genomics Market by Study Type

By study type, the market is classified into functional genomics, biomarker discovery, pathway analysis, epigenomics, and others. The epigenomics segment dominated the market in 2023 in terms of revenue and is expected to dominate the market during the forecast period

Global Genomics Market by Technology

Based on technology, the Genomics Market is segmented into sequencing, PCR, flow cytometry, microarrays, and others. In 2023, the sequencing segment dominated the market in terms of revenue and is expected to be the same during the upcoming years.

Global Genomics Market by Product & Services

                

Based on Product & Services, the Genomics Market is segmented into consumables & reagents, services, and instruments, systems & software. The consumables & reagents segment is expected to dominate the market during the forecast period.

Global Genomics Market by Application

            

Based on application, the Genomics Market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. The drug discovery & development segment is expected to dominate the market during the forecast period.

Geographical Analysis of Global Genomics Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Genomics Market value followed by Asia Pacific. There are several factors contributing to the growth of the genomics market in the region. These include favorable initiatives by government and private bodies, as well as the increasing adoption of NGS and PCR-based diagnostics. Additionally, there has been a rise in the number of genomics startups and an increase in cancer research. Growing awareness of genomics services has also played a role, along with the presence of major players in the market, such as Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Danaher Corporation (US).

Key Players

The Genomics Market Report includes players such as Oxford Nanopore Technologies (U.K), Danaher Corporation (U.S), Thermo Fisher Scientific Inc. (U.S), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S), Bio-Rad Laboratories (U.S), Agilent Technologies (U.S), Eppendorf (Germany), GE Healthcare Inc. (U.S), among others.

Recent Developments

  • In March 2023, Illumina, Inc (US) has introduced Connected Insights, a new cloud-based platform that enables tertiary analysis of clinical next-generation sequencing data. This program will aid in genomic profiling (CGP) for advanced malignancies, whole-genome sequencing for uncommon disorders, and other sophisticated applications.
  • In February 2023, Eppendorf AG (Germany) expanded its production facilities in China by securing a contract to develop a new plant in Shanghai.
  • In February 2023, TrueMark STI Select Panel, a polymerase chain reaction (PCR) test developed for research purposes only, detects Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium.
  • In October 2022, Oxford Nanopore Technologies (UK) worked with 10x Genomics (US) to create a simplified approach for sequencing full-length transcripts in single reads using easily accessible Oxford Nanopore devices.
Genomics Market Report Coverage:
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current Genomics Market outlook and estimations from 2023 to 2033, which helps to recognize the prevalent opportunities.
  • The report also covers qualitative as well as quantitative analysis of Genomics Market in terms of revenue ($Million).
  •  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Genomics industry.
  • A thorough analysis of market trends and restraints is provided.
  •  By region as well as country market analysis is also presented in this report.
  • Analytical depiction of the Genomics Market along with the current trends and future estimations to depict imminent investment pockets. The overall Genomics industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
  • Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Genomics Market are also analyzed.

Frequently Asked Questions

Q1. How big is the Genomics Market?

Ans. The global Genomics Market size was US$ 45.9 billion in 2023 and is anticipated to reach US$ 126.8 billion in 2033, growing at a rate of 10.5% from 2023 to 2033.

Q2. What is the Genomics Market growth rate?

Ans. The growth rate of the Genomics Market is 10.5% from 2023 to 2033.

Q3. Which region holds a major market share for the Genomics Market?

Ans. North America holds a major market share of the Genomics Market in 2022.

Q4. Which segment accounted for the largest Genomics Market share?

Ans. Based on end user, the Genomics Market is segmented into hospitals & clinics, academic & research institutes, pharmaceutical & biotechnology companies, and others. The academic & research institutes segment is expected to dominate the market during the forecast period.

Q5. Who are the key players in the Genomics Market?

Ans. The global Genomics Market report includes players such as Oxford Nanopore Technologies (U.K), Danaher Corporation (U.S), Thermo Fisher Scientific Inc. (U.S), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S), Bio-Rad Laboratories (U.S), Agilent Technologies (U.S), Eppendorf (Germany), GE Healthcare Inc. (U.S), among others.

Q6. What are the factors driving the Genomics Market growth?

Ans. The major factor driving the growth of the market is the increasing demand for personalized medicine and the increasing funding for genomics research..

Q7. What are the key growth strategies of Genomics Market players?

Ans. The key growth strategies of Genomics Market players are product launch, partnerships, and government initiatives.

Q8. Which region will provide more business opportunities for the Genomics Market during the forecast period?

Ans. The North America region will provide more business opportunities for the Genomics Market during the forecast period.

 

Why GIS?

 

Table of Contents

Chapter 1. Genomics Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Type
3.3. Market Attractiveness Analysis, by Technology
3.4. Market Attractiveness Analysis, by Application
3.5. Market Attractiveness Analysis, by End-Use

Chapter 4. Genomics Market Outlook
4.1. Genomics Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Genomics Market
4.7. Impact of the Russia and Ukraine War on the Genomics Market
4.8. Case Study Analysis
4.9. Pricing Analysis

Chapter 5. Genomics Market, by Type
5.1. Market Overview
5.2. Consumable
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region
5.3. Software
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region
5.4. Services
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region

Chapter 6. Genomics Market, by Technology
6.1. Market Overview
6.2. PCR
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Sequencing
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Microarray
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region
6.5. Nucleic Acid Extraction and Purification
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Size and Forecast, by Region
6.6. Others

Chapter 7. Genomics Market, by Application
7.1. Market Overview
7.2. Diagnostics
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region
7.3. Drug Discovery and Development
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Precision Medicine
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. Agriculture and Animal Research
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region
7.6. Others
7.6.1. Key Market Trends & Opportunity Analysis
7.6.2. Market Size and Forecast, by Region

Chapter 8. Genomics Market, by End-Use
8.1. Market Overview
8.2. Research Centers and Academic Institutes
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. Market Size and Forecast, by Region
8.3. Hospitals & Clinics
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Market Size and Forecast, by Region
8.4. Pharmaceutical & Biotechnology Companies
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Market Size and Forecast, by Region
8.5. Others
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Market Size and Forecast, by Region

Chapter 9. Genomics Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Genomics Market Size and Forecast, by Type
9.2.3. North America Genomics Market Size and Forecast, by Application
9.2.4. North America Genomics Market Size and Forecast, by Technology
9.2.5. North America Genomics Market Size and Forecast, by End-Use
9.2.6. North America Genomics Market Size and Forecast, by Country
9.2.7. The U.S.
9.2.7.1. The U.S. Genomics Market Size and Forecast, by Type
9.2.7.2. The U.S. Genomics Market Size and Forecast, by Application
9.2.7.3. The U.S. Genomics Market Size and Forecast, by Technology
9.2.7.4. The U.S. Genomics Market Size and Forecast, by End-Use
9.2.8. Canada
9.2.8.1. Canada Genomics Market Size and Forecast, by Type
9.2.8.2. Canada Genomics Market Size and Forecast, by Application Concentrators
9.2.8.3. Canada Genomics Market Size and Forecast, by Technology
9.2.8.4. Canada Genomics Market Size and Forecast, by End-Use
9.2.9. Mexico
9.2.9.1. Mexico Genomics Market Size and Forecast, by Type
9.2.9.2. Mexico Genomics Market Size and Forecast, by Application
9.2.9.3. Mexico Genomics Market Size and Forecast, by Technology
9.2.9.4. Mexico Genomics Market Size and Forecast, by End-Use
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Genomics Market Size and Forecast, by Type
9.3.3. Europe Genomics Market Size and Forecast, by Application
9.3.4. Europe Genomics Market Size and Forecast, by Technology
9.3.5. Europe Genomics Market Size and Forecast, by End-Use
9.3.6. Europe Genomics Market Size and Forecast, by Country
9.3.7. The UK
9.3.7.1. The UK Genomics Market Size and Forecast, by Type
9.3.7.2. The UK Genomics Market Size and Forecast, by Application
9.3.7.3. The UK Genomics Market Size and Forecast, by Technology
9.3.7.4. The UK Genomics Market Size and Forecast, by End-Use
9.3.8. Germany
9.3.8.1. Germany Genomics Market Size and Forecast, by Type
9.3.8.2. Germany Genomics Market Size and Forecast, by Application
9.3.8.3. Germany Genomics Market Size and Forecast, by Technology
9.3.8.4. Germany Genomics Market Size and Forecast, by End-Use
9.3.9. France
9.3.9.1. France Genomics Market Size and Forecast, by Type
9.3.9.2. France Genomics Market Size and Forecast, by Application
9.3.9.3. France Genomics Market Size and Forecast, by Technology
9.3.9.4. France Genomics Market Size and Forecast, by End-Use
9.3.10. Spain
9.3.10.1. Spain Genomics Market Size and Forecast, by Type
9.3.10.2. Spain Genomics Market Size and Forecast, by Application
9.3.10.3. Spain Genomics Market Size and Forecast, by Technology
9.3.10.4. Spain Genomics Market Size and Forecast, by End-Use
9.3.11. Italy
9.3.11.1. Italy Genomics Market Size and Forecast, by Type
9.3.11.2. Italy Genomics Market Size and Forecast, by Application
9.3.11.3. Italy Genomics Market Size and Forecast, by Technology
9.3.11.4. Italy Genomics Market Size and Forecast, by End-Use
9.3.12. Netherlands
9.3.12.1. Netherlands Genomics Market Size and Forecast, by Type
9.3.12.2. Netherlands Genomics Market Size and Forecast, by Application
9.3.12.3. Netherlands Genomics Market Size and Forecast, by Technology
9.3.12.4. Netherlands Genomics Market Size and Forecast, by End-Use
9.3.13. Sweden
9.3.13.1. Sweden Genomics Market Size and Forecast, by Type
9.3.13.2. Sweden Genomics Market Size and Forecast, by Application
9.3.13.3. Sweden Genomics Market Size and Forecast, by Technology
9.3.13.4. Sweden Genomics Market Size and Forecast, by End-Use
9.3.14. Switzerland
9.3.14.1. Switzerland Genomics Market Size and Forecast, by Type
9.3.14.2. Switzerland Genomics Market Size and Forecast, by Application
9.3.14.3. Switzerland Genomics Market Size and Forecast, by Technology
9.3.14.4. Switzerland Genomics Market Size and Forecast, by End-Use
9.3.15. Denmark
9.3.15.1. Denmark Genomics Market Size and Forecast, by Type
9.3.15.2. Denmark Genomics Market Size and Forecast, by Application
9.3.15.3. Denmark Genomics Market Size and Forecast, by Technology
9.3.15.4. Denmark Genomics Market Size and Forecast, by End-Use
9.3.16. Finland
9.3.16.1. Finland Genomics Market Size and Forecast, by Type
9.3.16.2. Finland Genomics Market Size and Forecast, by Application
9.3.16.3. Finland Genomics Market Size and Forecast, by Technology
9.3.16.4. Finland Genomics Market Size and Forecast, by End-Use
9.3.17. Russia
9.3.17.1. Russia Genomics Market Size and Forecast, by Type
9.3.17.2. Russia Genomics Market Size and Forecast, by Application
9.3.17.3. Russia Genomics Market Size and Forecast, by Technology
9.3.17.4. Russia Genomics Market Size and Forecast, by End-Use
9.3.18. Rest of Europe
9.3.18.1. Rest of Europe Genomics Market Size and Forecast, by Type
9.3.18.2. Rest of Europe Genomics Market Size and Forecast, by Application
9.3.18.3. Rest of Europe Genomics Market Size and Forecast, by Technology
9.3.18.4. Rest of Europe Genomics Market Size and Forecast, by End-Use
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Genomics Market Size and Forecast, by Country
9.4.3. Asia-Pacific Genomics Market Size and Forecast, by Type
9.4.4. Asia-Pacific Genomics Market Size and Forecast, by Application
9.4.5. Asia-Pacific Genomics Market Size and Forecast, by Technology
9.4.6. Asia-Pacific Genomics Market Size and Forecast, by End-Use
9.4.7. China
9.4.7.1. China Genomics Market Size and Forecast, by Type
9.4.7.2. China Genomics Market Size and Forecast, by Application
9.4.7.3. China Genomics Market Size and Forecast, by Technology
9.4.7.4. China Genomics Market Size and Forecast, by End-Use
9.4.8. India
9.4.8.1. India Genomics Market Size and Forecast, by Type
9.4.8.2. India Genomics Market Size and Forecast, by Application
9.4.8.3. India Genomics Market Size and Forecast, by Technology
9.4.8.4. India Genomics Market Size and Forecast, by End-Use
9.4.9. Japan
9.4.9.1. Japan Genomics Market Size and Forecast, by Type
9.4.9.2. Japan Genomics Market Size and Forecast, by Application
9.4.9.3. Japan Genomics Market Size and Forecast, by Technology
9.4.9.4. Japan Genomics Market Size and Forecast, by End-Use
9.4.10. South Korea
9.4.10.1. South Korea Genomics Market Size and Forecast, by Type
9.4.10.2. South Korea Genomics Market Size and Forecast, by Application
9.4.10.3. South Korea Genomics Market Size and Forecast, by Technology
9.4.10.4. South Korea Genomics Market Size and Forecast, by End-Use
9.4.11. Australia
9.4.11.1. Australia Genomics Market Size and Forecast, by Type
9.4.11.2. Australia Genomics Market Size and Forecast, by Application
9.4.11.3. Australia Genomics Market Size and Forecast, by Technology
9.4.11.4. Australia Genomics Market Size and Forecast, by End-Use
9.4.12. Singapore
9.4.12.1. Singapore Genomics Market Size and Forecast, by Type
9.4.12.2. Singapore Genomics Market Size and Forecast, by Application
9.4.12.3. Singapore Genomics Market Size and Forecast, by Technology
9.4.12.4. Singapore Genomics Market Size and Forecast, by End-Use
9.4.13. Indonesia
9.4.13.1. Indonesia Genomics Market Size and Forecast, by Type
9.4.13.2. Indonesia Genomics Market Size and Forecast, by Application
9.4.13.3. Indonesia Genomics Market Size and Forecast, by Technology
9.4.13.4. Indonesia Genomics Market Size and Forecast, by End-Use
9.4.14. Taiwan
9.4.14.1. Taiwan Genomics Market Size and Forecast, by Type
9.4.14.2. Taiwan Genomics Market Size and Forecast, by Application
9.4.14.3. Taiwan Genomics Market Size and Forecast, by Technology
9.4.14.4. Taiwan Genomics Market Size and Forecast, by End-Use
9.4.15. Malaysia
9.4.15.1. Malaysia Genomics Market Size and Forecast, by Type
9.4.15.2. Malaysia Genomics Market Size and Forecast, by Application
9.4.15.3. Malaysia Genomics Market Size and Forecast, by Technology
9.4.15.4. Malaysia Genomics Market Size and Forecast, by End-Use
9.4.16. Rest of APAC
9.4.16.1. Rest of APAC Genomics Market Size and Forecast, by Type
9.4.16.2. Rest of APAC Genomics Market Size and Forecast, by Application
9.4.16.3. Rest of APAC Genomics Market Size and Forecast, by Technology
9.4.16.4. Rest of APAC Genomics Market Size and Forecast, by End-Use
9.5. Rest of The World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of The World Genomics Market Size and Forecast, by Type
9.5.3. Rest of The World Genomics Market Size and Forecast, by Application
9.5.4. Rest of The World Genomics Market Size and Forecast, by Technology
9.5.5. Rest of The World Genomics Market Size and Forecast, by End-Use
9.5.6. Rest of The World Genomics Market Size and Forecast, by Country
9.5.7. Latin America
9.5.7.1. Latin America Genomics Market Size and Forecast, by Type
9.5.7.2. Latin America Genomics Market Size and Forecast, by Application
9.5.7.3. Latin America Genomics Market Size and Forecast, by Technology
9.5.7.4. Latin America Genomics Market Size and Forecast, by End-Use
9.5.8. Middle East
9.5.8.1. Middle East Genomics Market Size and Forecast, by Type
9.5.8.2. Middle East Genomics Market Size and Forecast, by Application
9.5.8.3. Middle East Genomics Market Size and Forecast, by Technology
9.5.8.4. Middle East Genomics Market Size and Forecast, by End-Use
9.5.9. Africa
9.5.9.1. Africa Genomics Market Size and Forecast, by Type
9.5.9.2. Africa Genomics Market Size and Forecast, by Application
9.5.9.3. Africa Genomics Market Size and Forecast, by Technology
9.5.9.4. Africa Genomics Market Size and Forecast, by End-Use

Chapter 10. Competitive Landscape
10.1. Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Vendor Benchmarking
10.4. Developmental Strategy Benchmarking
10.4.1. New Product Developments
10.4.2. Product Launches
10.4.3. Business Expansions
10.4.4. Partnerships, Joint Ventures, and Collaborations
10.4.5. Mergers and Acquisitions

Chapter 11. Company Profiles
11.1. Oxford Nanopore Technologies (U.K)
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Type s
11.1.4. Key Developmental Strategies
11.1.5. SWOT Analysis
11.2. Danaher Corporation. (U.S)
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Product Type s
11.2.4. Key Developmental Strategies
11.2.5. SWOT Analysis
11.3. Thermo Fisher Scientific Inc (U.S)
11.3.1. Company Snapshot
11.3.2. Financial Performance
11.3.3. Product Type s
11.3.4. Key Developmental Strategies
11.3.5. SWOT Analysis
11.4. F. Hoffmann La Roche Ltd (Switzerland)
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Product Type s
11.4.4. Key Developmental Strategies
11.4.5. SWOT Analysis
11.5. Eurofins Scientific (Luxembourg)
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Product Type s
11.5.4. Key Developmental Strategies
11.5.5. SWOT Analysis
11.6. Illumina (U.S)
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Product Type s
11.6.4. Key Developmental Strategies
11.6.5. SWOT Analysis
11.7. Bio Rad Laboratories (U.S)
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Product Type s
11.7.4. Key Developmental Strategies
11.7.5. SWOT Analysis
11.8. Agilent Technologies. (U.S)
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Product Type s
11.8.4. Key Developmental Strategies
11.8.5. SWOT Analysis
11.9. Eppendorf (Germany)
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Product Type s
11.9.4. Key Developmental Strategies
11.9.5. SWOT Analysis
11.10. GE Healthcare Inc. (U.S)
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Product Type s
11.10.4. Key Developmental Strategies
11.10.5. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report

Market Segmentation:

By Products and Services

  • Consumables & Reagents
  • Services
  • Instruments, Systems & Software

By Technology

  • PCR
  • Sequencing
  • Microarray
  • Flow Cytometry
  • Others

By Application

  • Diagnostics
  • Drug Discovery and Development
  • Agriculture and Animal Research
  • Others

By Study Type

  • Functional Genomics
    • Transfection
    • Real-Time PCR
    • RNA Interference
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
  • Epigenomics
    • Bisulfite Sequence
    • High-Resolution Melt
    • Microarray Analysis
    • Chromatin Accessibility
  • Pathway Analysis
    • Bead-Based Analysis
    • Microarray Analysis
    • Real-Time PCR
    • Proteomics Tools
  • Biomarker Discovery
    • Mass Spectrometry
    • DNA Sequencing
    • Bioinformatics
    • Statistical Analysis
    • Real-Time PCR
  • Others

By End-Use

  • Research Centers and Academic Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America
    • The U.S.
    •  Canada
    •  Mexico
  • Europe
    • The U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Netherlands
    • Sweden
    • Switzerland
    • Denmark
    • Finland
    • Russia
    •  Rest of Europe
  • The Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    •  Australia
    • Singapore
    • Indonesia
    • Taiwan
    • Malaysia
    • Rest of Asia-Pacific
  •  Rest of the World
    •  Latin America
    •  The Middle East
    •  Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The global Nanoparticle Analysis Market was valued at…
Clinical trial supplies are the materials and products…
Visual Arts Therapy is an integrative form of…
Allergic rhinitis (hay fever) is an allergic reaction…
Monoclonal antibody therapy is a treatment that uses…
The global Whole Exome Sequencing Market was valued…
Graft Versus Host disease (GVHD) is an immune…
Pharmacokinetics services provide a comprehensive evaluation of drugs,…
Venous thrombosis occurs due to the blockage of…
Keloid treatment is a medical procedure used to…